Stock listing
Frankfurt:7AL0 Alligator Bioscience AB Aktie
German listing (Frankfurt) of Alligator Bioscience AB · home listing Stockholm:ATORX
Follow Alligator Bioscience AB into a list and get an email when it puts out news.
Share price · FWB:7AL0
€0.0001 EUR 0.0000 (0.0%)
Close on Oct 23, 2026
- Day range
- €0.0001 – €0.0001 EUROct 23, 2026
- Market cap
- €356,810 EURAt the close on Oct 23, 2026 · price × 3.57B shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:ATORX · Home | 0.01 SEK | -0.001 (-4.7%) | 122,973,635 | 0.011 | 0.011 | 0.0096 | 0.011 | Close on Oct 23, 2026 |
| Frankfurt:7AL0 | €0.0001 EUR | 0.0000 (0.0%) | — | €0.0001 | €0.0001 | €0.0001 | €0.0001 | Close on Oct 23, 2026 |
- Ticker
- Frankfurt:7AL0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 4, 2026
Alligator Bioscience appoints Johan Giléus as CEO – Søren Bregenholt to step down at year-end
Latest earnings call · Aug 26, 2026
Alligator Bioscience (Stockholm:ATORX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 15 slides
Calls
Replays
Alligator Bioscience (Stockholm:ATORX) Q2 2026 Earnings Call
Wed, Aug 26, 2026 · 9:00 AM ET
Watch TranscriptAlligator Bioscience (Stockholm:ATORX) Q1 2026 Earnings Call
Tue, May 05, 2026 · 7:00 AM ET
Watch TranscriptAlligator Bioscience (Stockholm:ATORX) Q4 2025 Earnings Call
Thu, Feb 12, 2026 · 9:00 AM ET
Watch Transcript
Latest news
Financings
Rights offering of units of ordinary shares and warrants series TO 15 and TO 16
Sep 22, 2026 · US$5.97M
Closed: SEK 58.8M raised · SEK 0.04 a unit · each unit consists of two ordinary shares, one warrant series TO 15 and one warrant… · APREA Partners AB +1
Dealers: APREA Partners AB, Vator Securities AB
Buyers: Roxette Photo S.A. (part of subscription undertakings totaling SEK 2 million); Søren Bregenholt (part of subscription undertakings totaling SEK 2 million); Vator Securities AB (guarantee commitments totaling SEK 56.8 million together with Mangold); Mangold Fondkommission AB (guarantee commitments totaling SEK 56.8 million together with Vator Securities)
Insiders: Existing shareholders including CEO Søren Bregenholt have entered into subscription undertakings totaling SEK 2 million
Use of proceeds: Repayment of bridge loans of SEK 19 million
Announced Jul 23, 2026 · Update Aug 26, 2026 · Update Aug 31, 2026 · Closed Sep 22, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 15 slides · September 2026
Q2 2026 Earnings Presentation
Earnings · 28 slides · Aug 26, 2026
Q1 2026 Earnings Presentation
Earnings · 28 slides · May 5, 2026
Investor Presentation (September 2025)
Investor deck · 32 slides · September 2025
Alligator Bioscience AB on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 36 in the last 12 months · 76 in all · newest Oct 4, 2026 · oldest 2025
- Calls
- 10 calls with a replay · 10 with a transcript · latest Aug 26, 2026
- Decks
- 17 decks · latest September 2026
Where Alligator Bioscience AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:ATORX · Home listing | Stockholm | Sweden | SEK |
| LSE:0RK9 | LSE | United Kingdom | SEK |
| LS Exchange:A41BED | LS Exchange | Germany | EUR |
| Lang & Schwarz:A41BED | Lang & Schwarz | Germany | EUR |
| Aquis:ATORXS | Aquis | United Kingdom | SEK |
| Frankfurt:7AL0 · This page | Frankfurt | Germany | EUR |
| Aquis:ATORXS | Aquis | United Kingdom | SEK |
| Stuttgart:7AL0 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Alligator Bioscience AB.